Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cediranib in Alveolar Soft Part Sarcoma
NCT00942877Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jul 2009
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cediranib in alveolar soft part sarcoma (ASPS), sponsored by National Cancer Institute. Started Jul 2009; status: completed.
02
Drugs
cediranib
03
Conditions
alveolar soft part sarcoma (ASPS)
Beyond the preview
Go deeper on NCT00942877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00942877.